Table 4.
TCM | Method | Animal | Cell | Mechanism | Toxic substances | Reference |
---|---|---|---|---|---|---|
PF | Aβ25–35 | / | C6 glial | NEP↑ 、IDE↑ NOS↓、COX2↓、NO↓ IL-6↓、IL-1β↓、TNF-α↓ |
Aβ↓ | (162) E. J. Cho, et al,2020 |
DNLA | SAMP8 | Mice | BV2 | NEP↑ 、IDE↑ | Aβ↓、p-Tau↓ | (130) C. Z. Feng,et al,2019 |
NTR1 | APP/PS1 | Mice | N2a-APP695sw | IDE↑、 | Aβ↓ | (156) Z. Li, et al,2015 |
Magnolol | TgCRND8 | Mice | / | NEP↑ 、IDE↑ Astrocyte and microglia density↓ |
APP↓BACE1↓APH1↓PS1↓ Aβ↓、p-Tau↓ |
(128) C. Qu,et al,2021 |
IRN | TgCRND8 Aβ42 |
Mice | PRHN | IDE↑ Astrocyte and microglia density↓、IL-6↓、IL-1β↓、TNF-α↓ |
APP↓BACE1↓APH1↓ Aβ↓、p-Tau↓ |
(122) H. Q. Li,et al,2019 |
AA13 | Aβ1-42 | Mice | PMA | NEP↑ 、IDE↑ Microglia convert from M1 to M2↑ |
Aβ↓ | (163) C. Huang, et al,2017 |
RP02-1 | / | / | CHO/APPBACE1 | NEP↑ 、IDE↑ | Aβ↓ | (165) H. Zeng, et al,2020 |
LBP1C-2 | / | / | CHO/APPBACE1 | IDE↑ | BACE1↓ADAM10↑ Aβ↓ |
(166) L. Zhou, et al,2018 |
Rg1 | Aβ1-42 | Rats | / | IDE↑ | APP↓BACE1↓PS1↓ADAM10↑ Aβ↓ |
(169) S. Zhi Liu, et al,2019 |
F1 | APP/PS1 Aβ1-42 |
Mice | N2aAPP695sw SH-SY5Y |
NEP↑ 、IDE↑ | Aβ↓ | (170) Y. J. Yun, et al, 2022 |
Rb1 | STZ | Mice | / | IDE↑ | (164) R. Yang, et al, 2020 | |
DNLA | HMD | Mice | / | NEP↑ 、IDE↑ | APP↓BACE1↓PS1↓DNMT1↓ Aβ↓ |
(167) T. Pi, et al,2021 |
STS | / | / | SH-SY5Y SH-SY5YAPPsw |
NEP↑ 、IDE↑ ROS↓、MDA↓、NO↓、iNOS↓、SOD↑、GSH↑ IL-6↓、IL-1β↓、TNF-α↓ |
BACE1↓ADAM10↑ Aβ↓ |
(168) X. Q. Liu, et al,2020 |
CIG | 3×Tg | Mice | / | NEP↑ 、IDE↑ NGF↑、BDNF↑、p-CREB↑ |
/ | (171) C. Yang, et al, 2020 |
EFAD | HFD | Mice | 3T3-L1 | IDE↑ | Aβ↓、p-tau↓ | (124) S. Bin Park, et al, 2019 |
IDE, Iinsulin degrading enzyme; NGF, nerve growth factor; PMA, Primary microglia and astrocytes.
The '↑' means up-regulation and '↓' means down-regulation.